Abstract
Human herpesvirus 6 (HHV-6) is being increasingly associated with multiple neurological conditions. The authors report the case of a 26-year-old man with subacute meningoradiculitis initially treated with intravenous immunoglobulin. The cerebrospinal fluid (CSF) showed pleocytosis and polymerase chain reaction (PCR) was positive for HHV-6 type B DNA in the CSF and peripheral blood. He was subsequently treated with valganciclovir with near resolution of his symptoms.
MeSH terms
-
Adult
-
Antiviral Agents / therapeutic use*
-
DNA, Viral / blood
-
DNA, Viral / cerebrospinal fluid
-
Ganciclovir / analogs & derivatives*
-
Ganciclovir / therapeutic use
-
Herpesvirus 6, Human*
-
Humans
-
Immunoglobulins, Intravenous / therapeutic use*
-
Leukocytosis / cerebrospinal fluid
-
Male
-
Meningitis / therapy*
-
Meningitis / virology
-
Polymerase Chain Reaction
-
Radiculopathy / therapy*
-
Radiculopathy / virology
-
Roseolovirus Infections / complications
-
Roseolovirus Infections / therapy*
-
Treatment Outcome
-
Valganciclovir
Substances
-
Antiviral Agents
-
DNA, Viral
-
Immunoglobulins, Intravenous
-
Valganciclovir
-
Ganciclovir